Patents by Inventor Geoffrey V. McGarraugh

Geoffrey V. McGarraugh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120283542
    Abstract: The invention relates to a method for calibrating an analyte-measurement device that is used to evaluate a concentration of analyte in bodily fluid at or from a measurement site in a body. The method involves measuring a concentration, or calibration concentration, of an analyte in blood from an “off-finger” calibration site, and calibrating the analyte-measurement device based on that calibration concentration. The invention also relates to a device, system, or kit for measuring a concentration of an analyte in a body, which employs a calibration device for adjusting analyte concentration measured in bodily fluid based on an analyte concentration measured in blood from an “off-finger” calibration site.
    Type: Application
    Filed: July 9, 2012
    Publication date: November 8, 2012
    Applicant: Abbott Diabetes Care Inc.
    Inventor: Geoffrey V. McGarraugh
  • Patent number: 8260558
    Abstract: Methods and apparatus for providing data processing and control for use in a medical communication system are provided.
    Type: Grant
    Filed: May 14, 2008
    Date of Patent: September 4, 2012
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Gary Hayter, Geoffrey V. McGarraugh, Kenneth J. Doniger
  • Patent number: 8239166
    Abstract: Methods and apparatus for providing data processing and control for use in a medical communication system are provided.
    Type: Grant
    Filed: May 14, 2008
    Date of Patent: August 7, 2012
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Gary Hayter, Geoffrey V. McGarraugh, Andrew H. Naegeli, John C. Mazza, Benjamin J. Feldman
  • Publication number: 20120197576
    Abstract: The invention relates to a method for calibrating an analyte-measurement device that is used to evaluate a concentration of analyte in bodily fluid at or from a measurement site in a body. The method involves measuring a concentration, or calibration concentration, of an analyte in blood from an “off-finger” calibration site, and calibrating the analyte-measurement device based on that calibration concentration. The invention also relates to a device, system, or kit for measuring a concentration of an analyte in a body, which employs a calibration device for adjusting analyte concentration measured in bodily fluid based on an analyte concentration measured in blood from an “off-finger” calibration site.
    Type: Application
    Filed: April 4, 2012
    Publication date: August 2, 2012
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Benjamin J. Feldman, Geoffrey V. McGarraugh
  • Patent number: 8216138
    Abstract: The invention relates to a method for calibrating an analyte-measurement device that is used to evaluate a concentration of analyte in bodily fluid at or from a measurement site in a body. The method involves measuring a concentration, or calibration concentration, of an analyte in blood from an “off-finger” calibration site, and calibrating the analyte-measurement device based on that calibration concentration. The invention also relates to a device, system, or kit for measuring a concentration of an analyte in a body, which employs a calibration device for adjusting analyte concentration measured in bodily fluid based on an analyte concentration measured in blood from an “off-finger” calibration site.
    Type: Grant
    Filed: October 23, 2008
    Date of Patent: July 10, 2012
    Assignee: Abbott Diabetes Care Inc.
    Inventor: Geoffrey V. McGarraugh
  • Patent number: 8219175
    Abstract: The invention relates to a method for calibrating an analyte-measurement device that is used to evaluate a concentration of analyte in bodily fluid at or from a measurement site in a body. The method involves measuring a concentration, or calibration concentration, of an analyte in blood from an “off-finger” calibration site, and calibrating the analyte-measurement device based on that calibration concentration. The invention also relates to a device, system, or kit for measuring a concentration of an analyte in a body, which employs a calibration device for adjusting analyte concentration measured in bodily fluid based on an analyte concentration measured in blood from an “off-finger” calibration site.
    Type: Grant
    Filed: June 29, 2009
    Date of Patent: July 10, 2012
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Benjamin J. Feldman, Geoffrey V. McGarraugh
  • Patent number: 8219174
    Abstract: The invention relates to a method for calibrating an analyte-measurement device that is used to evaluate a concentration of analyte in bodily fluid at or from a measurement site in a body. The method involves measuring a concentration, or calibration concentration, of an analyte in blood from an “off-finger” calibration site, and calibrating the analyte-measurement device based on that calibration concentration. The invention also relates to a device, system, or kit for measuring a concentration of an analyte in a body, which employs a calibration device for adjusting analyte concentration measured in bodily fluid based on an analyte concentration measured in blood from an “off-finger” calibration site.
    Type: Grant
    Filed: June 29, 2009
    Date of Patent: July 10, 2012
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Benjamin J. Feldman, Geoffrey V. McGarraugh
  • Publication number: 20120165637
    Abstract: The invention relates to a method for calibrating an analyte-measurement device that is used to evaluate a concentration of analyte in bodily fluid at or from a measurement site in a body. The method involves measuring a concentration, or calibration concentration, of an analyte in blood from an “off-finger” calibration site, and calibrating the analyte-measurement device based on that calibration concentration. The invention also relates to a device, system, or kit for measuring a concentration of an analyte in a body, which employs a calibration device for adjusting analyte concentration measured in bodily fluid based on an analyte concentration measured in blood from an “off-finger” calibration site.
    Type: Application
    Filed: March 8, 2012
    Publication date: June 28, 2012
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Benjamin J. Feldman, Geoffrey V. McGarraugh
  • Patent number: 8116840
    Abstract: The invention relates to a method for calibrating an analyte-measurement device that is used to evaluate a concentration of analyte in bodily fluid at or from a measurement site in a body. The method involves measuring a concentration, or calibration concentration, of an analyte in blood from an “off-finger” calibration site, and calibrating the analyte-measurement device based on that calibration concentration. The invention also relates to a device, system, or kit for measuring a concentration of an analyte in a body, which employs a calibration device for adjusting analyte concentration measured in bodily fluid based on an analyte concentration measured in blood from an “off-finger” calibration site.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: February 14, 2012
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Benjamin J. Feldman, Geoffrey V. McGarraugh
  • Publication number: 20110193704
    Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.
    Type: Application
    Filed: August 30, 2010
    Publication date: August 11, 2011
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Wesley Scott Harper, Annie C. Tan, Timothy Christian Dunn, Mark Kent Sloan, Kenneth J. Doniger, Geoffrey V. McGarraugh, Michael Love, Phillip Yee, Gary Alan Hayter, Marc Barry Taub, Thomas A. Peyser, Michael A. Pani, R. Curtis Jennewine, Glenn Howard Berman
  • Patent number: 7996158
    Abstract: Methods and apparatus for providing data processing and control for use in a medical communication system are provided.
    Type: Grant
    Filed: May 14, 2008
    Date of Patent: August 9, 2011
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Gary Hayter, Geoffrey V. McGarraugh, Andrew H. Naegeli, John C. Mazza, Benjamin J. Feldman, Wesley Scott Harper
  • Patent number: 7920907
    Abstract: Devices and methods for monitoring an analyte are provided. Embodiments include continuous analyte sensors having a high degree of accuracy.
    Type: Grant
    Filed: June 7, 2007
    Date of Patent: April 5, 2011
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Geoffrey V. McGarraugh, Benjamin J. Feldman, Thomas A. Peyser, John C. Mazza, Timothy T. Goodnow, Kerstin Rebrin
  • Publication number: 20110077494
    Abstract: Method and apparatus for determining and outputting projected alarms or notifications associated with anticipated hyperglycemic or hypoglycemic conditions are provided. Systems and kits employing the devices described herein executing the one or more routines described are also provided.
    Type: Application
    Filed: September 29, 2010
    Publication date: March 31, 2011
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Kenneth J. Doniger, Glenn Howard Berman, Geoffrey V. McGarraugh
  • Publication number: 20110004084
    Abstract: The invention relates to a method for calibrating an analyte-measurement device that is used to evaluate a concentration of analyte in bodily fluid at or from a measurement site in a body. The method involves measuring a concentration, or calibration concentration, of an analyte in blood from an “off-finger” calibration site, and calibrating the analyte-measurement device based on that calibration concentration. The invention also relates to a device, system, or kit for measuring a concentration of an analyte in a body, which employs a calibration device for adjusting analyte concentration measured in bodily fluid based on an analyte concentration measured in blood from an “off-finger” calibration site.
    Type: Application
    Filed: September 17, 2010
    Publication date: January 6, 2011
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Benjamin J. Feldman, Geoffrey V. McGarraugh
  • Publication number: 20100292948
    Abstract: The invention relates to a method for calibrating an analyte-measurement device that is used to evaluate a concentration of analyte in bodily fluid at or from a measurement site in a body. The method involves measuring a concentration, or calibration concentration, of an analyte in blood from an “off-finger” calibration site, and calibrating the analyte-measurement device based on that calibration concentration. The invention also relates to a device, system, or kit for measuring a concentration of an analyte in a body, which employs a calibration device for adjusting analyte concentration measured in bodily fluid based on an analyte concentration measured in blood from an “off-finger” calibration site.
    Type: Application
    Filed: July 26, 2010
    Publication date: November 18, 2010
    Inventors: Benjamin J. Feldman, Geoffrey V. McGarraugh
  • Publication number: 20100282616
    Abstract: The invention relates to a method for calibrating an analyte-measurement device that is used to evaluate a concentration of analyte in bodily fluid at or from a measurement site in a body. The method involves measuring a concentration, or calibration concentration, of an analyte in blood from an “off-finger” calibration site, and calibrating the analyte-measurement device based on that calibration concentration. The invention also relates to a device, system, or kit for measuring a concentration of an analyte in a body, which employs a calibration device for adjusting analyte concentration measured in bodily fluid based on an analyte concentration measured in blood from an “off-finger” calibration site.
    Type: Application
    Filed: July 26, 2010
    Publication date: November 11, 2010
    Inventors: Benjamin J. Feldman, Geoffrey V. McGarraugh
  • Publication number: 20100230285
    Abstract: Methods and systems for providing continuous analyte monitoring including in vivo sensors that do not require any user calibration during in vivo use are provided. Also provided are methods and devices including continuous analyte monitoring systems that include in vivo sensors which do not require any system executed calibration or which do not require any factory based calibration, and which exhibit stable sensor sensitivity characteristics. Methods of manufacturing the no calibration sensors and post manufacturing packaging and storage techniques are also provided.
    Type: Application
    Filed: February 26, 2010
    Publication date: September 16, 2010
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Udo Hoss, Christopher Allen Thomas, Geoffrey V. McGarraugh, Gary Alan Hayter
  • Patent number: 7768386
    Abstract: Methods and apparatus for providing data processing and control for use in a medical communication system are provided.
    Type: Grant
    Filed: July 31, 2007
    Date of Patent: August 3, 2010
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Gary Hayter, Geoffrey V. McGarraugh, Andrew H. Naegeli, John C. Mazza, Benjamin J. Feldman
  • Publication number: 20100121167
    Abstract: Methods and apparatus including determining a rate of occurrence of a glycemic excursion event, determining a frequency of an alarm activation associated with the glycemic excursion event, determining an analyte level associated with the alarm activation, and setting an alarm parameter based on one or more of the determined rate of occurrence of the glycemic excursion event, the frequency of the alarm activation associated with the glycemic excursion event or the determined analyte level are provided.
    Type: Application
    Filed: November 10, 2009
    Publication date: May 13, 2010
    Applicant: Abbott Diabetes Care Inc.
    Inventor: Geoffrey V. McGarraugh
  • Publication number: 20090281406
    Abstract: Devices and methods for monitoring an analyte are provided. Embodiments include continuous analyte sensors having a high degree of accuracy.
    Type: Application
    Filed: July 20, 2009
    Publication date: November 12, 2009
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Geoffrey V. McGarraugh, Benjamin J. Feldman, Thomas A. Peyser, John C. Mazza, Timothy T. Goodnow, Kerstin Rebrin